id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-3295-0003,FDA,FDA-2019-E-3295,Letter to U.S. Patent and Trademark Office from FDA CDER,Other,Letter(s),2019-10-29T04:00:00Z,2019,10,2019-10-29T04:00:00Z,,2019-10-29T20:13:20Z,,0,0,0900006484106fa0
FDA-2019-E-3295-0002,FDA,FDA-2019-E-3295,"Patent Extension Application from Servilla Whitney LLC (on behalf of Amicus Therapeutics, Inc.)",Other,Application,2019-07-09T04:00:00Z,2019,7,2019-07-09T04:00:00Z,,2019-07-09T14:39:24Z,,0,0,0900006483d6e2ca
FDA-2019-E-3295-0001,FDA,FDA-2019-E-3295,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-07-09T04:00:00Z,2019,7,2019-07-09T04:00:00Z,,2019-07-09T14:32:41Z,,0,0,0900006483d6e2c9